Member Info for bogyo

Isb, all I am saying is that the sp dropped but its a weak drop. So I have nothing to worry about this as I dont see a selloff on this drop to continue. Its corrective and will likely reverse, as it did many times in the last few months. Yes there has been no major impulse yet up but the sentiment is supporting a next bullish move. We are still making higher lows no structure is broken and we are still moving up.
I also expect a news to trigger this substantially further.

Price dropped but there was no volume to support, so the selloff is weak and it will reverse up. All uptrend moves are supported by volume increase which is showing the main trend. This area now is a buy in zone for bigger gains. Anyone who can buy at these ~3p price is just lucky.

everyone is getting in ahead of Monday news...

breaking so quickly? thats some movement for today... ahead of some good news after taking the CEO shares.

Lets see how the 10p trend line will react this time. 3 times touched, 4th usually breaks.
My scenario is a large Cup to 15p, then a tiny handle back to 12-13p, then roseypinkponiespoopingbutterflies.

If only those mice inventory were tokenised on SYME, and Hemo would be a cryptotoken. We would be Mooning for no apparent reason.

Pushing down the price to buy more? There must be something in the background for this sudden volatility.
We are at a strong trendline so even if we drops under 3, it will probably just wick down and ignite larger buy backs.

This was aired a few days ago on BBC in the last news, my wife just asked me if this is what all our life saving is in? My heart got pumping from excitement, but then I thought not that Tesla **** again... just when the lady was saying "I do trust technology, but I dont like that humans dont have to keep their EYE on the road". Well said, I dont like that either. Did you see that light up steering wheel in the BBC news darling? nobody wants to tell us where it is coming from and thats where all our money in and is doing exactly what is needed for this next development step. I know what that is, and trust our money will be doing well.

Another interview that crashes the sp, or an RNS without substance that crashes the sp - careful what you wish for. I'd rather listen to the silence and wait for an approval or an RNS with proper news, when its time.

I just looked up what is Syme doing for their SP rise.
I demand x100 on HEMO sp tomorrow! And all my other investments. Not kidding.

we all saw that 7M and then 3M (wonder who that bought?) purchase this week, still puzzled why not moved the SP? Maybe soon it will move

JHFH wow mate, you also need to take a day off :)
I just wonder why you were not thinking about the field mouse...

Probably you all heard about Synairgen, who worked with University Hospital Southampton on clinical trial Ph1. Yes it is Covid so urgency is different, but timelines were Ph1 start announced March 2020. Positive first results Jul 2020. SP went from 6p to 210p now. Analogy is the same with Hemo and University of Pennsylvania. And this is only one of their pipelines, we did not even expect news from it.
Working with a Principal Investigator directly on a trial runs at different interest and is much quicker to achieve results.
Positive PoC will drive to Phase1 the SP will rocket on this news itself.
Potential here is bigger than selling at 9p :)
DYOR

that is a huge volume spike. It should follow with a price movement.

Funny how some selling because they dont see another (third) giant Pharma named. They obviously have no clue how research works. Giant pharma is a way to move you towards to this same stage, to the Principal Investogators research centre to do the clinical trial. Pharma pays the PI to do the research for their clinical resources and time, PI doesnt care much gets the money. The success is at the end with the Pharma.
Today announcement - the research is agreed with the PI directly and they spend their resources and time to do the clinical trial. They dont need mulitplies of funding spent by giant Pharmas because they commit their time and resource to it, they do care about it much much more and they have everything they need to do a trial. Huge step in moving things forward and scientifically this way is much more efficient. They have all the funds they need to do the clinical trial. Investigator Initiated clinical tirals are much more cost effective and are more liked by regulators as well. Pharma will be in picture very soon and we are on their radar.
Btw, I work in giant Pharma so I know what I am in here. Just read again the bit about Novartis in the RNS guys.
DYOR

Like the way they write RNS's and put in the collaborators CV and mention previous breakthrough Novartis drug successes to translate to the PIs what they are actually reading.

If this is how its RNSed it is concerning and I doubt it would be the case of knowingly underpromoting our value. If they are aware of any significant info that would have an impact on our forecast it should be RNSed and clarified. If our product is planned in an upcoming model it is possibly in agreement with SEE and should be well known therefore forecast in the financials. So maybe these model plans our not entirely clear in the numbers and the agreements are so vague that allow such wide range of different scenarios.
I still think revised numbers in RNS should come first before we see unexpected extra millions in cash in our financial results.

well actually there is a 5% spread, so just MM play. no real volume yet on these trades.
Still a good start to mark up to 8p.

not celebrating but a sudden 5% pop for no reason is quite unusual if looking back to it nothing really happened. Such things always follow through later on if they are volume based.

what just happened?

gap close, low volume, testing support, or just market disappointed in the fish eye camera angle.